Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3009224	ts-egfrish	— (—)	163	172	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Epilepsy

101

53.29

176.81

1.1

1.0

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

159

+∞

167.20

1.1

0.0

—

Malignant neoplasm of brain, including Hilmo

158

+∞

166.90

1.1

0.0

—

Malignant neoplasm of eye, brain and central nervous system

154

+∞

162.93

1.1

0.0

—

Malignant neoplasm of brain

153

+∞

162.59

1.1

0.0

—

Focal epilepsy

85.64

160.75

1.1

1.0

—

Focal epilepsy, strict definition

83.68

156.50

1.1

1.0

—

Any death

113

44.03

141.40

1.1

1.0

—

Brain glioblastoma and astrocytoma

121

+∞

130.28

1.1

0.0

—

Brain glioblastoma, helper endpoint

100

+∞

107.95

1.1

0.0

—

Brain glioblastoma

100

+∞

107.95

1.1

0.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

90.83

73.00

1.1

1.0

—

Other medical care

14.41

71.89

1.1

1.0

—

First line medication for Crohn's disease

13.89

58.36

1.0

—

Convulsions, not elsewhere classified

16.09

45.43

1.1

1.0

—

Persons encountering health services for specific procedures and health care

6.15

34.47

1.1

1.0

—

Episodal and paroxysmal disorders

7.50

32.55

1.0

—

Brain astrocytoma

+∞

22.39

1.0

0.0

—

Brain astrocytoma, including Hilmo

+∞

22.39

1.0

0.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

+∞

18.53

1.1

0.0

—

Neurological diseases

6.58

17.31

1.0

—

Any reimbursement code in KELA

17.54

11.34

1.0

—

Care involving use of rehabilitation procedures

4.21

10.90

1.1

1.0

—

Intracranial trauma

6.75

10.87

1.0

—

General symptoms and signs

3.29

10.18

1.0

—

Stroke, excluding SAH

3.50

9.11

1.1

1.0

—

Stroke, including SAH

3.34

8.49

1.1

1.0

—

Oxycodone

3.71

7.29

1.1

—

Intracerebral haemorrhage

10.85

7.28

1.2

1.0

—

DVT of lower extremities and pulmonary embolism

3.59

6.95

1.0

—

STROKE

2.95

6.72

1.1

1.0

—

Cerebrovascular diseases

2.86

6.64

1.1

1.0

—

Nontraumatic intracranial haemmorrhage

7.78

6.60

1.1

1.0

—

Cerebrovascular diseases (FINNGEN)

3.31

6.37

1.1

1.0

—

Abnormal findings on diagnostic imaging of central nervous system

15.05

5.90

1.0

—

Visual field defects

12.88

5.58

1.1

1.0

—

Malaise and fatigue

3.18

5.25

1.1

1.0

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

+∞

5.22

1.0

0.0

—

Non-Hodgkin lymphoma, all, including Hilmo

+∞

5.21

1.0

0.0

—

Venous thromboembolism

2.82

5.17

1.0

—

Liquid cancers

+∞

5.10

1.0

0.0

—

Colorectal cancer, including Hilmo

+∞

5.07

1.0

0.0

—

Delirium, not induced by alcohol and other psychoactive substances

7.68

4.83

1.0

—

Headache

2.77

4.77

1.2

1.0

—

Neurological diseases, wide definition

6.70

4.54

1.0

—

Concussion

5.04

4.46

1.0

—

All chronic kidney diseases

0.00

4.45

0.0

1.0

—

Ischaemic Stroke, excluding all haemorrhages

2.68

4.45

1.0

—

Pulmonary heart disease

3.42

4.17

1.0

—

Pulmonary embolism

3.42

4.17

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

3.42

4.17

1.0

—

Benign neoplasm of brain and other parts of central nervous system

12.02

3.76

1.0

—

Ischemic heart diseases

122

0.24

3.69

1.6

1.0

—

Major coronary heart disease event

124

0.24

3.68

1.6

1.0

—

Renal failure

0.00

3.53

0.0

1.0

—

Artrosis, including avohilmo

127

0.30

3.36

1.1

—

Purpura and other haemorrhagic conditions

5.34

3.19

1.0

—

Use of hypnotics and sedatives

114

1.90

3.15

1.1

1.0

—

Arthrosis

112

0.29

3.10

1.2

1.1

—

Fever of other and unknown origin

2.47

3.05

1.1

1.0

—

Other pulmonary diagnosis

101

0.30

2.99

1.0

—

4.29

2.99

1.1

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

4.29

2.99

1.0

—

Bleeding

101

2.01

2.94

1.1

1.0

—

Speech therapy

3.44

2.89

1.0

—

Gonarthrosis,primary

117

0.31

2.77

1.2

1.0

—

Hydrocephalus

8.34

2.75

1.0

—

Thrombocytopenia, unspecified

8.34

2.75

1.0

—

Excluding asthma or asthma-COPD overlap

101

0.35

2.57

1.0

—

Inflammatory diseases of the central nervous system

7.15

2.55

1.0

—

Autoimmune diseases related-to ILD

154

0.33

2.54

1.0

1.1

—

Traumatic subdural haemorrhage

6.68

2.43

1.0

—

Benign neoplasm of meninges

5.01

2.40

1.2

1.0

—

Cerebral palsy and other paralytic syndromes

5.00

2.40

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

2.40

0.0

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

0.00

2.40

0.0

1.0

—

DVT of lower extremities

3.34

2.39

1.0

—

Statin medication

101

0.33

2.38

1.0

—

Elevated blood glucose level

6.26

2.37

1.0

—

Ischaemic heart disease, wide definition

108

0.34

2.36

1.7

1.0

—

Polyarthropathies

113

0.34

2.35

1.0

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.00

2.31

0.0

1.0

—

All kidney diseases

146

0.41

2.25

1.0

1.1

—

Combinations of oral blood glucose lowering drugs

0.00

2.24

0.0

1.0

—

Obesity related asthma

0.00

2.23

0.0

1.0

—

Other specified/unspecified arthritis

0.00

2.21

0.0

1.0

—

Fentanyl

5.55

2.21

1.0

—

Finngen Rheumatological endpoints

138

0.41

2.15

1.1

—

Dermatitis and eczema

151

0.43

2.11

1.1

—

Herpesviral [herpes simplex] infections

5.00

2.07

1.0

—

COPD differential diagnosis

0.40

2.05

1.0

—

ILD differential diagnosis

0.40

2.05

1.0

—

Disturbances of skin sensation

2.63

2.00

1.0

—

Other and unspecified effects of external causes

2.63

2.00

1.0

—

Sleep apnoea, including avohilmo

141

0.43

1.97

1.0

1.1

—

Bacterial infection, other or unspecified

2.00

1.94

1.0

—

Abnormal findings on diagnostic imaging of other body structures

3.75

1.93

1.0

—

Degenerative diseases of the nervous system

0.00

1.92

0.0

1.1

—

Alzheimer disease, including avohilmo

0.00

1.90

0.0

1.1

—

Hypertension, essential

106

0.43

1.90

1.1

—

Bacterial infection, other or unspecified, including avohilmo

1.95

1.90

1.0

—

Chronic kidney disease

0.00

1.89

0.0

1.0

—

Dental operations

0.37

1.87

1.0

1.1

—

Deforming dorsopathies

0.00

1.85

0.0

1.0

—

Arthropathies

122

0.46

1.84

1.0

1.1

—

Inflammatory bowel disease treatment related agents

147

0.49

1.79

1.0

1.1

—

Other (not insulin) diabetes medications

131

0.45

1.78

1.0

1.1

—

Caries of enamel

145

0.45

1.77

1.0

1.1

—

Abnormal involuntary movements

3.34

1.74

1.0

—

Oral corticosteroids

145

0.48

1.73

1.0

1.1

—

Polyarthrosis

0.00

1.72

0.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

122

1.64

1.71

1.0

1.1

—

L02BA Anti-estrogens

3.85

1.71

1.0

1.1

—

Benzodiazepine use

129

1.62

1.69

1.0

1.1

—

Biguanides

131

0.46

1.67

1.0

1.1

—

Sleep apnoea

136

0.46

1.65

1.0

1.1

—

Fitting and adjustment of other devices

2.61

1.65

1.0

—

Opioids

1.66

1.65

1.0

—

Exclusions for E4_PCOS_BROAD

2.80

1.64

1.0

—

Unspecified lump in breast

3.57

1.61

1.0

1.1

—

Cholecystitis

3.57

1.61

1.0

—

Syncope and collapse

2.18

1.61

1.0

—

Nerve, nerve root and plexus disorders

144

0.50

1.60

1.0

1.1

—

Dental pulpitis, including avohilmo

136

0.47

1.59

1.1

—

Hypertension

106

0.48

1.58

1.1

—

Hypertensive diseases

106

0.48

1.58

1.1

—

Genitourinary diseases

0.46

1.56

1.0

—

Asthma (only as main-diagnosis), excluding more controls

0.46

1.54

1.1

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

117

1.57

1.54

1.1

1.0

—

Angina pectoris

0.38

1.53

1.2

1.0

—

Diseases of arteries, arterioles and capillaries

0.39

1.53

1.0

—

Chronic lower respiratory diseases

145

0.54

1.52

1.1

1.0

—

Calcific aortic valvular stenosis, operated

0.00

1.52

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

1.52

0.0

1.0

—

Operations 2 for CAVS

0.00

1.52

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

1.52

0.0

1.0

—

Functional dyspepsia

0.00

1.52

0.0

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

1.52

0.0

1.0

—

Other joint disorders

122

0.51

1.48

1.0

1.1

—

Other bacterial diseases

116

1.60

1.47

1.0

1.1

—

Other neurological diseases

101

1.69

1.46

1.1

1.0

—

Other headache syndromes

2.49

1.44

1.0

—

Abnormalities of breathing

123

0.51

1.40

1.0

1.1

—

Symptoms and signs involving speech and voice

2.17

1.39

1.1

1.0

—

Other nutritional deficiencies

128

0.43

1.39

1.0

—

severe traumatic brain injury, does not include concussion

2.41

1.39

1.0

—

Atopic dermatitis

0.40

1.38

1.0

—

Misadventures to patients during surgical and medical care

2.94

1.36

1.0

—

Alzheimer disease

0.00

1.35

0.0

1.0

—

Ganglion

0.00

1.34

0.0

1.0

—

Conjunctivitis (acute, non atopic)

2.13

1.33

1.0

—

Type 2 diabetes, strict (exclude DM1)

130

0.54

1.32

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

0.44

1.32

1.5

1.0

—

Fracture at wrist and hand level

1.96

1.31

1.0

—

Disorders of eyelid, lacrimal system and orbit

131

0.50

1.30

1.0

—

Complications of procedures, not elsewhere classified

122

1.58

1.29

1.1

1.0

—

Presence of other functional implants

0.42

1.28

1.2

1.0

—

Diseases of male genital organs

0.48

1.28

1.0

—

Codeine or tramadol medication

141

0.58

1.28

1.0

—

Obesity

127

0.44

1.27

1.0

—

Obesity and other hyperalimentation

127

0.44

1.27

1.0

—

Type 2 diabetes

127

0.55

1.25

1.0

1.1

—

105

0.42

1.25

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

123

0.57

1.24

1.1

—

Diverticular disease of intestine

0.47

1.24

1.3

1.0

—

Asthma (only as main-diagnosis)

0.51

1.24

1.1

1.0

—

Other arrhythmias

108

0.48

1.23

1.1

1.0

—

Visual disturbances

1.77

1.22

1.1

1.0

—

Other disorders of skin and subcutaneous tissue

122

0.48

1.21

1.0

—

Renal tubulo-interstitial diseases

126

0.52

1.20

1.0

—

Other bacterial diseases, including avohilmo

126

1.49

1.19

1.0

1.1

—

Later onset COPD, excluding more controls

0.00

1.18

0.0

1.0

—

Asthma

0.53

1.18

1.1

1.0

—

Hard cardiovascular diseases

100

1.54

1.18

1.2

1.0

—

Use of other anti-dementia drugs

0.00

1.17

0.0

1.0

—

Use of memantine

0.00

1.17

0.0

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

131

0.57

1.16

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

141

0.59

1.16

1.0

1.1

—

Necrosis of pulp, including avohilmo

125

0.47

1.16

1.0

1.1

—

Other diseases of hard tissues of teeth

0.49

1.16

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

0.49

1.16

1.0

1.1

—

Asthma (mode)

0.53

1.16

1.1

1.0

—

Acute renal failure

0.00

1.16

0.0

1.0

—

Other noninfective gastroenteritis and colitis

0.00

1.15

0.0

1.0

—

Later onset COPD

0.00

1.15

0.0

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

134

0.58

1.14

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.44

1.14

1.0

—

Alcohol use disorder, Swedish definition

102

0.45

1.13

1.0

1.1

—

Asthma, excluding more controls

0.53

1.13

1.1

1.0

—

Visual disturbances and blindness

1.68

1.13

1.1

1.0

—

Other reaction to severe stress, and adjustment disorders

1.84

1.13

1.0

—

Diabetes medication

138

0.59

1.12

1.0

1.1

—

Enthesopathies of lower limb, excluding foot

2.00

1.12

1.0

—

ILD medications

119

1.45

1.11

1.1

1.0

—

Artificial joint operation, meniscal resection

126

0.56

1.10

1.1

—

Superficial injury of wrist and hand

2.26

1.10

1.0

—

Periodontitis

141

0.59

1.09

1.1

—

Asthma, hospital admissions , main diagnosis only

144

0.54

1.08

1.1

1.0

—

Used for control exclusion in common control thyroid runs

118

0.60

1.07

1.1

1.0

—

Type 2 diabetes, definitions combined

121

0.58

1.07

1.0

1.1

—

Meniscus derangement

102

0.52

1.06

1.1

—

107

0.49

1.06

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

126

0.60

1.05

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

124

1.47

1.05

1.0

1.1

—

Asthma/COPD (KELA code 203)

145

0.60

1.03

1.2

1.0

—

Voice disturbances

2.06

1.02

1.1

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

137

0.60

1.02

1.0

1.1

—

Other specific joint derangements/joint disorders

119

0.58

1.00

1.1

—

Asthma, including avohilmo

146

0.64

1.00

1.1

—

Nasal polyp

2.00

1.00

1.3

1.0

—

Disorders of tooth development and eruption

0.00

0.99

0.0

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.99

0.0

1.0

—

Medical observation and evaluation for suspected diseases and conditions

0.53

0.98

1.3

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

0.00

0.98

0.0

1.0

—

Asthma and allergy

0.00

0.97

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

0.97

0.0

1.0

—

Valvular operations

0.00

0.97

0.0

1.0

—

Spondylolisthesis/Spondylolysis

0.00

0.97

0.0

1.0

—

Alzheimer’s disease, strict definition

0.00

0.97

0.0

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

123

0.62

0.96

1.0

—

Foreign body on external eye

0.00

0.96

0.0

1.0

—

Superficial injury of head

0.00

0.96

0.0

1.0

—

Other heart diseases, wide

136

0.62

0.95

1.1

—

Non-allergic asthma (mode), excluding more controls

0.00

0.94

0.0

1.0

—

Non-allergic asthma (mode)

0.00

0.94

0.0

1.0

—

Dentofacial anomalies [including malocclusion]

114

0.55

0.94

1.0

1.1

—

Substance abuse, excluding more controls

101

0.50

0.94

1.0

—

Mental and behavioural disorders due to psychoactive substance use

108

0.51

0.94

1.0

1.1

—

Asthma, hospital admission 2, infections

117

0.50

0.93

1.0

—

Asthma-related infections

117

0.50

0.93

1.0

—

Autoimmune diseases

126

0.64

0.92

1.1

—

Dizziness and giddiness

103

1.51

0.92

1.0

—

Other antidepressants

120

0.64

0.91

1.0

—

All anxiety disorders

0.55

0.89

1.0

1.1

—

Mental and behavioural disorders due to alcohol

0.49

0.89

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

100

0.53

0.89

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

121

1.43

0.89

1.0

1.1

—

Conjunctivitis

108

1.49

0.88

1.0

—

Chronic periodontitis, including avohilmo

140

0.64

0.88

1.1

—

Diseases of the respiratory system

0.55

0.87

1.0

—

Selective serotonin reuptake inhibitors

120

0.65

0.85

1.2

1.0

—

Myocardial infarction

0.53

0.85

1.5

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

122

0.63

0.85

1.1

—

Disorders of synovium and tendon

0.52

0.83

1.0

—

Substance abuse

106

0.53

0.83

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

1.62

0.82

1.0

—

Supervision of normal pregnancy

0.00

0.82

0.0

1.0

—

Antenatal screening

0.00

0.81

0.0

1.0

—

Sensorineural hearing loss

100

0.60

0.81

1.0

—

Other diseases of intestines

133

0.67

0.80

1.1

—

Asthma (diagnoses ohter than nonallergic)

143

0.62

0.80

1.0

—

Childhood allergy (age < 16)

0.00

0.80

0.0

1.0

—

Inflammatory diseases of female pelvic organs

0.51

0.80

1.2

1.0

—

Other cataract

0.50

0.79

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

0.79

0.0

1.0

—

Acute nasopharyngitis (common cold)

0.00

0.79

0.0

1.0

—

Generalized anxiety disorder

0.00

0.79

0.0

1.0

—

Thoracic aortic aneurysm

0.00

0.79

0.0

1.0

—

Bacterial intestinal infections, IBD co-morbidities

0.00

0.79

0.0

1.0

—

Other bacterial intestinal infections

0.00

0.79

0.0

1.0

—

Pedal cyclist injured in transport accident

1.82

0.79

1.3

1.0

—

Unspecified acute lower respiratory infection

0.00

0.79

0.0

1.0

—

Special screening examination for other diseases and disorders

0.00

0.79

0.0

1.0

—

Pollen allergy

0.00

0.79

0.0

1.0

—

Dyspnoea

136

0.64

0.78

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

0.78

0.0

1.0

—

Glomerular diseases

0.00

0.78

0.0

1.0

—

Glaucoma

0.50

0.78

1.0

—

ILD medications: immunosuppressive drugs

113

0.56

0.78

1.0

—

Symptoms and signs involving the digestive system and abdomen

113

0.66

0.77

1.0

1.1

—

Hernia

133

0.65

0.77

1.0

1.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

0.00

0.77

0.0

1.0

—

Gout, strict definition

0.00

0.77

0.0

1.0

—

Biological medication for rheuma

0.00

0.77

0.0

1.0

—

Asthma and allergy, excluding more controls

0.00

0.77

0.0

1.0

—

Spondylopathies

0.61

0.77

1.0

1.1

—

Implicit Sepsis, including avohilmo

117

1.40

0.76

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

143

0.67

0.76

1.1

—

Disorders of conjunctiva

121

1.41

0.75

1.0

—

Hypertensive diseases (excluding secondary)

0.55

0.75

1.0

—

Persons encountering health services in circumstances related to reproduction

0.60

0.75

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.70

0.75

1.1

1.0

—

Certain infectious and parasitic diseases

1.39

0.74

1.0

—

Intracranial injury

100

1.49

0.74

1.0

—

Injuries to the wrist and hand

132

1.36

0.73

1.0

1.1

—

Acute sinusitis

0.56

0.72

1.0

1.1

—

Chronic periodontitis, complicated

106

0.55

0.72

1.0

—

Fracture of lower leg, including ankle

107

0.55

0.72

1.0

—

124

0.69

0.72

1.1

1.0

—

Second line medication for Crohn's disease

110

0.54

0.71

1.0

—

Subjective visual disturbances

1.75

0.71

1.0

1.1

—

Type 2 diabetes, wide definition

116

0.65

0.71

1.0

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

142

0.71

1.1

—

Complications of medical and surgical care

120

1.42

0.71

1.1

1.0

—

Pain in throat and chest

123

0.67

0.71

1.1

—

Sleep disorders (combined)

133

0.71

0.70

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

101

1.48

0.69

1.1

1.0

—

Conductive and sensorineural hearing loss

105

0.63

0.68

1.0

—

Complications of surgical and medical care, not elsewhere classified

129

1.34

0.68

1.1

1.0

—

Cholecystectomy

107

1.43

0.68

1.1

1.0

—

Implicit viral Sepsis

1.85

0.68

1.0

—

Viral Sepsis

1.85

0.68

1.0

—

Hypo-osmolality and hyponatraemia

1.84

0.68

1.2

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

103

1.44

0.67

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

0.61

0.66

1.0

—

Injuries to the knee and lower leg

136

0.71

0.66

1.1

—

Bacterial pneumonia (organism specified)

1.55

0.66

1.0

—

Transport accidents

1.49

0.65

1.1

1.0

—

Rotator cuff syndrome

0.60

0.65

1.0

1.1

—

Migraine

1.77

0.65

1.0

—

Other strabismus

1.72

0.63

1.0

—

Single delivery by caesarean section

0.00

0.63

0.0

1.0

—

Triptan medication for migraine, min. 3 purchases

0.58

0.63

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

134

1.31

0.63

1.0

1.1

—

Paracetamol or NSAID medication

0.00

0.63

0.0

1.1

—

Spondylosis

0.57

0.62

1.0

—

Bacterial pneumonia, not elsewhere classified

1.56

0.62

1.0

—

L04AX Other immunosuppressants

104

0.58

0.61

1.0

—

All pneumoniae

134

1.31

0.61

1.0

1.1

—

Diabetic nephropathy, excluding more controls

0.00

0.61

0.0

1.1

—

Dementia in Alzheimer disease

0.00

0.61

0.0

1.1

—

Diabetic retinopathy, strict definition

0.00

0.61

0.0

1.1

—

Congenital malformations of the circulatory system

0.00

0.60

0.0

1.0

—

Crohn disease

0.00

0.60

0.0

1.0

—

Enlarged lymph nodes

0.00

0.60

0.0

1.0

—

Pre-eclampsia or eclampsia

0.00

0.60

0.0

1.1

—

Flat foot [pes planus] (acquired)

0.00

0.60

0.0

1.1

—

Abnormal spermatozoa

0.00

0.60

0.0

1.0

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.60

0.0

1.0

—

Trigger finger

0.00

0.60

0.0

1.0

—

Orchitis and epididymitis

0.00

0.59

0.0

1.0

—

Seronegative rheumatoid arthritis

0.00

0.59

0.0

1.0

—

Other condition

0.00

0.59

0.0

1.0

—

Insulin, fast-acting (human)

0.00

0.59

0.0

1.0

—

Pregnancy with abortive outcome

0.55

0.59

1.2

1.0

—

Use of donepezil

0.00

0.58

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

0.58

0.0

1.0

—

Tumor necrosis factor alpha inhibitors

0.00

0.58

0.0

1.0

—

All influenza (not pneumonia)

0.00

0.58

0.0

1.0

—

Implicit viral Sepsis, including avohilmo

1.51

0.58

1.0

—

Diseases of pulp and periapical tissues and dental caries

0.66

0.58

1.0

1.1

—

Sleep disorders

136

0.71

0.57

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

0.66

0.57

1.0

—

Fall on same level involving ice and snow

114

0.61

0.57

1.0

—

Presence of cardiac and vascular implants and grafts

0.56

0.57

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.67

0.57

1.0

1.1

—

Herpesviral [herpes simplex] infections, including avohilmo

1.67

0.56

1.0

—

Open wound of wrist and hand

0.58

0.56

1.0

1.1

—

Caries of dentine, including avohilmo

0.70

0.56

1.1

—

Other functional intestinal disorders

0.55

0.56

1.0

—

Carpal tunnel syndrome

109

0.64

0.54

1.0

—

Diseases of the digestive system

1.50

0.54

1.0

—

Cellulitis

1.58

0.54

1.2

1.0

—

Organic, including symptomatic, mental disorders

1.45

0.54

1.0

—

Inguinal hernia

0.67

0.53

1.0

1.1

—

Oedema, not elsewhere classified

1.54

0.53

1.0

—

Symptoms and signs involving the urinary system

111

0.68

0.52

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

0.67

0.52

1.0

—

Mycoses, including avohilmo

147

0.72

0.52

1.1

1.0

—

Insulin, intermediate and long-acting

0.62

0.52

1.0

—

Internal derangement of knee

0.62

0.52

1.0

—

Insomnia

134

0.73

0.51

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

120

0.75

0.51

1.1

1.0

—

Depression

136

0.74

0.50

1.0

1.1

—

Parasetamol

1.33

0.50

1.0

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

107

1.37

0.50

1.1

1.0

—

Mood disorders

137

0.75

0.49

1.1

—

Mood [affective] disorders

137

0.75

0.49

1.1

—

Bacterial pneumoniae

1.46

0.49

1.0

—

Medicines for HER+ breast cancer

1.55

0.49

1.0

1.1

—

Diabetes mellitus

130

0.75

0.48

1.1

—

Nausea and vomiting

1.55

0.48

1.1

1.0

—

Osteopathies and chondropathies

0.65

0.48

1.1

1.0

—

Erysipelas, including avohilmo

107

0.69

0.48

1.0

1.1

—

Mycoses

1.52

0.48

1.3

1.0

—

Abdominal and pelvic pain

113

0.76

0.48

1.0

1.1

—

Any gastric operation

0.72

0.47

1.0

1.1

—

GASTRO-related operations

0.72

0.47

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.47

0.46

1.0

—

Exposure to other specified factors

142

0.72

0.46

1.1

—

Codeine

0.72

0.46

1.0

—

Diabetes, varying definitions

129

0.76

0.45

1.1

—

Diseases of the ear and mastoid process

134

0.78

0.45

1.0

1.1

—

Cardiac arrhythmias

0.69

0.44

1.2

1.0

—

Asthma, unspecified (mode)

0.71

0.44

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

107

0.74

0.44

1.1

1.0

—

Other diseases of the digestive system

1.37

0.44

1.0

—

Diseases of the eye and adnexa

0.75

0.43

1.0

1.1

—

Persons encountering health services for examination and investigation

0.72

0.43

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

1.61

0.43

1.0

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1.41

0.42

1.3

1.0

—

Other degenerative diseases of the nervous system

0.00

0.42

0.0

1.0

—

Other intervertebral disc disorders

104

0.74

0.42

1.0

1.1

—

Congenital malformations of heart and great arteries

0.00

0.41

0.0

1.0

—

Presbycusis

0.00

0.41

0.0

1.1

—

Nonischemic cardiomyopathy

0.00

0.41

0.0

1.0

—

Transplanted organ and tissue status

0.00

0.41

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

0.41

0.0

1.0

—

Dilated cardiomyopathy

0.00

0.41

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

0.41

0.0

1.0

—

L04AD Calcineurin inhibitors

0.00

0.41

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

0.41

0.0

1.0

—

Other superficial mycoses, including avohilmo

0.00

0.41

0.0

1.0

—

Lichen planus

0.00

0.41

0.0

1.1

—

Restless leg syndrome

0.00

0.41

0.0

1.0

—

Diabetic nephropathy

0.00

0.41

0.0

1.1

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.40

0.0

1.0

—

Examination and encounter for administrative purposes

0.00

0.40

0.0

1.0

—

Reactive arthropathies

0.00

0.40

0.0

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.40

0.0

1.0

—

Diabetic maculopathy, excluding more controls

0.00

0.40

0.0

1.0

—

Hydronephrosis

0.00

0.40

0.0

1.0

—

Other disorders of kidney and ureter

0.00

0.40

0.0

1.0

—

Disturbance of activity and attention

0.00

0.40

0.0

1.0

—

Disorders of choroid and retina

113

0.74

0.40

1.0

—

Nephropathy related operations

0.00

0.40

0.0

1.0

—

Acute and transient psychotic disorders

0.00

0.40

0.0

1.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.40

0.0

1.0

—

Methotrexate

0.00

0.40

0.0

1.1

—

Pre-eclampsia

0.00

0.40

0.0

1.1

—

Phobic anxiety disorders

0.00

0.40

0.0

1.0

—

Sciatica+with lumbago

0.69

0.39

1.0

—

Triptan medication for migraine, single purchase ok

109

0.75

0.39

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

109

0.75

0.39

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

139

0.78

0.39

1.1

—

Osteoporosis

1.44

0.39

1.0

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

108

1.24

0.39

1.0

—

108

1.24

0.39

1.0

—

Injuries to the ankle and foot

127

0.74

0.39

1.1

—

Thiazolidinediones

0.00

0.39

0.0

1.0

—

Follow-up examination after treatment for malignant neoplasms

0.00

0.39

0.0

1.0

—

Dialysis, with operation codes

0.00

0.39

0.0

1.0

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.39

0.0

1.0

—

Noninfectious colitis NAS

0.00

0.39

0.0

1.0

—

Panic disorder

0.00

0.39

0.0

1.0

—

D07AA Corticosteroids, weak (group I)

0.00

0.39

0.0

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

136

1.22

0.38

1.0

1.1

—

Antihypertensive medication - note that there are other indications

0.74

0.38

1.0

—

Dermatitis

133

0.73

0.37

1.1

1.0

—

COPD/asthma related infections

108

0.79

0.37

1.0

—

COPD/asthma/ILD related infections

108

0.79

0.37

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

109

0.71

0.37

1.1

1.0

—

Cervicalgia

1.35

0.37

1.2

1.0

—

Strabismus

1.35

0.37

1.0

—

Other disorders of veins

1.28

0.36

1.0

—

Unspecified haematuria

0.64

0.36

1.0

—

Other diseases of pleura

0.65

0.36

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

129

0.80

0.36

1.0

1.1

—

Asthma, unspecified (mode), excluding more controls

0.72

0.35

1.0

—

Mouth breathing

0.66

0.35

1.0

—

Hyperlipidaemia, other/unspecified

0.62

0.35

1.2

1.0

—

Other retinal disorders

0.71

0.35

1.0

—

Hernia of abdominal wall

0.62

0.35

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

125

0.81

0.35

1.1

1.0

—

Dermatophytosis, including avohilmo

131

0.75

0.34

1.0

1.1

—

Mood disorders, excluding more controls

118

0.80

0.33

1.1

—

Disorders of other endocrine glands

1.35

0.31

1.0

—

Other dorsopathies, not elsewhere classified

109

0.81

0.31

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.35

0.31

1.3

1.0

—

Other acute lower respiratory infections

0.72

0.31

1.1

1.0

—

Heart failure, not strict

0.77

0.30

1.0

—

Open wound of head

0.71

0.30

1.0

—

Other disorders of urethra and urinary system

1.25

0.30

1.1

1.0

—

Disorders of sclera, cornea, iris and ciliary body

100

0.70

0.30

1.0

—

Examination and observation for other reasons

1.25

0.30

1.1

1.0

—

Polycystic ovarian syndrome, consortium definition

0.73

0.30

1.0

1.1

—

Acute upper respiratory infections

131

0.82

0.29

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

1.24

0.29

1.4

1.0

—

Accidents

1.21

0.29

1.0

—

Other diseases of upper respiratory tract

125

0.83

0.29

1.1

1.0

—

Other and unspecified dermatitis

110

0.73

0.28

1.0

—

Acute appendicitis

129

1.22

0.28

1.0

1.1

—

Cardiovascular diseases

0.73

0.28

1.0

—

Other disorders of ear

126

0.82

0.27

1.0

—

Dental caries, including avohilmo

0.80

0.27

1.0

1.1

—

Hallux valgus (acquired)

0.69

0.26

1.0

1.1

—

Influenza and pneumonia

132

1.17

0.26

1.0

1.1

—

Non-selective monoamine reuptake inhibitors

0.69

0.26

1.0

—

Acute appendicitis, no complications

113

1.23

0.25

1.0

1.1

—

Intestinal infectious diseases

143

0.83

0.25

1.1

—

Shoulder lesions

102

0.82

0.24

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

0.82

0.23

1.0

—

Other abnormal uterine and vaginal bleeding

1.33

0.23

1.0

1.1

—

Periapical abscess

0.75

0.22

1.1

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

115

0.85

0.22

1.1

—

Provisional assignment of new diseases of uncertain etiology

0.74

0.22

1.1

1.0

—

Codes for special purposes

0.74

0.22

1.1

1.0

—

L02BG Aromatase inhibitors

1.23

0.22

1.0

1.1

—

Alzheimer disease, excluding more controls

0.00

0.22

0.0

1.0

—

Chronic gastritis

1.22

0.22

1.0

—

Infections, IBD-co-morbidities

0.00

0.22

0.0

1.0

—

Disorders of thyroid, IBD co-morbidities

0.00

0.22

0.0

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

0.21

0.0

1.0

—

Prepatellar bursitis

0.00

0.21

0.0

1.0

—

Alcohol-induced chronic pancreatitis

0.00

0.21

0.0

1.0

—

Social phobias

0.00

0.21

0.0

1.0

—

Reactive arthropathies, FINNGEN

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

1.0

—

Amputation

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.1

—

Foreign body entering into or through eye or natural orifice

0.00

0.21

0.0

1.0

—

Other and unspecified mood [affective] disorders

0.00

0.21

0.0

1.0

—

Mixed and other personality disorders

0.00

0.21

0.0

1.0

—

Bronchitis, not specified as acute or chronic

0.00

0.21

0.0

1.0

—

Other diseases of biliary tract

0.00

0.21

0.0

1.0

—

Vestibular neuronitis

0.00

0.21

0.0

1.0

—

Transient global amnesia

0.00

0.21

0.0

1.0

—

0.00

0.21

0.0

1.0

—

Ocular pain

0.00

0.21

0.0

1.0

—

L02BB Anti-androgens

0.00

0.21

0.0

1.0

—

Abnormal results of function studies

0.00

0.21

0.0

1.0

—

Female infertility, associated with anovulation

0.00

0.21

0.0

1.0

—

Other and unspecified rosacea

0.00

0.21

0.0

1.0

—

Stenosis and insufficiency of lacrimal passages

0.00

0.21

0.0

1.0

—

Other benign neoplasms of connective and other soft tissue

0.00

0.21

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.21

0.0

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

0.21

0.0

1.0

—

Other disorders of cornea

0.00

0.21

0.0

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Weight loss

0.00

0.21

0.0

1.0

—

Seborrhoeic dermatitis

0.00

0.21

0.0

1.0

—

Adalimumab

0.00

0.21

0.0

1.0

—

Other noninflammatory disorders of vulva and perineum

0.00

0.21

0.0

1.1

—

Vitamin B12 deficiency anaemia

0.00

0.21

0.0

1.0

—

Unspecified kidney failure

0.00

0.21

0.0

1.0

—

Diabetic neuropathy

0.00

0.21

0.0

1.1

—

Thyroiditis, ILD-related definition

0.00

0.21

0.0

1.0

—

Polycystic ovarian syndrome, broad definition

0.00

0.21

0.0

1.0

—

Unspecified/other endometriosis

0.00

0.21

0.0

1.2

—

Diseases of middle ear and mastoid

0.78

0.21

1.0

—

Myocarditis

0.00

0.21

0.0

1.0

—

Osteoporosis with pathological fracture (FG)

0.00

0.21

0.0

1.1

—

Cardiomyopathy, other and unspecified

0.00

0.21

0.0

1.0

—

Other diseases of pancreas

0.00

0.21

0.0

1.0

—

Idiopathic gout

0.00

0.21

0.0

1.0

—

Faecal incontinence

0.00

0.21

0.0

1.2

—

Glomerulonephritis

0.00

0.21

0.0

1.0

—

Vitreous haemorrhage

0.00

0.21

0.0

1.0

—

Perforation of tympanic membrane

0.00

0.21

0.0

1.0

—

Metatarsalgia

0.00

0.21

0.0

1.0

—

Impacted cerumen

0.00

0.21

0.0

1.0

—

COPD-related respiratory insufficiency

0.00

0.21

0.0

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.21

0.0

1.0

—

Other disorders of breast

0.00

0.21

0.0

1.1

—

Other metabolic disorders

0.00

0.21

0.0

1.0

—

Inflammatory disease of uterus

0.00

0.21

0.0

1.0

—

Symptoms and signs concerning food and fluid intake

0.00

0.21

0.0

1.0

—

Diabetic maculopathy

0.00

0.21

0.0

1.1

—

Otitis media, unspecified

0.00

0.21

0.0

1.0

—

Ulcerative rectosigmoiditis

0.00

0.21

0.0

1.0

—

Disorders of mineral metabolism

0.00

0.21

0.0

1.0

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.21

0.0

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.21

0.0

1.0

—

Disorders of continuity of bone

0.00

0.21

0.0

1.0

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

1.0

—

Other local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.21

0.0

1.0

—

Rosacea

0.00

0.21

0.0

1.0

—

Emotionally unstable personality disorder

0.00

0.21

0.0

1.0

—

Allergic contact dermatitis

0.00

0.21

0.0

1.0

—

Explicit bacterial Sepsis

0.00

0.21

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

0.21

0.0

1.0

—

Tooth eruption problems

0.00

0.20

0.0

1.0

—

Prolonged pregnancy

0.00

0.20

0.0

1.0

—

Constipation

120

0.85

0.20

1.0

—

Appendicitis, broad definition

130

1.17

0.20

1.0

1.1

—

Alcoholic liver disease

0.00

0.20

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

0.20

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

0.20

0.0

1.0

—

Chalazion

0.00

0.20

0.0

1.0

—

Explicit bacterial Sepsis, including avohilmo

0.00

0.20

0.0

1.0

—

Injuries to the head

136

1.13

0.20

1.0

1.1

—

GI-bleeding

1.20

0.19

1.0

—

Diseases of appendix

130

1.17

0.19

1.0

1.1

—

Asthma-related pneumonia

1.17

0.19

1.0

—

Asthma, hospital admissions 3, pneumonia

1.17

0.19

1.0

—

Asthma-related pneumonia or sepsis

1.17

0.19

1.0

—

Insulin medication

101

0.82

0.18

1.0

—

Other external causes of accidental injury

1.15

0.18

1.0

—

Urticaria and erythema

1.21

0.18

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

139

0.87

0.17

1.0

1.1

—

Certain infectious and parasitic diseases, including avohilmo

0.85

0.17

1.0

—

Implicit bacterial Sepsis

1.22

0.17

1.0

—

Insulin, fast-acting

0.76

0.17

1.0

—

Implicit bacterial Sepsis, including avohilmo

1.20

0.16

1.0

—

Gastro-oesophageal reflux disease

119

0.85

0.16

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

124

1.15

0.16

1.1

—

Falls/tendency to fall

112

1.12

0.16

1.0

—

Chronic diseases of tonsils and adenoids

109

0.87

0.16

1.0

—

Disorders of breast

1.10

0.16

1.0

1.1

—

Other and unspecified disorders of vitreous body

1.10

0.15

1.0

—

Dorsopathies

109

0.88

0.15

1.1

—

Other diseases of lip and oral mucosa

1.10

0.15

1.0

—

Other disorders of eyelid

0.79

0.15

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

138

1.13

0.15

1.0

1.1

—

Allergic conjunctivitis

1.18

0.15

1.0

—

Other maternal disorders predominantly related to pregnancy

0.80

0.15

1.0

1.1

—

Soft tissue disorders

115

0.89

0.15

1.1

—

Degeneration of macula and posterior pole

0.78

0.14

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

118

1.15

0.14

1.1

—

Tramadol

0.86

0.14

1.0

—

Benign neoplasms

110

0.89

0.13

1.2

1.0

—

Pain in joint

0.84

0.13

1.0

—

Other soft tissue disorders, not elsewhere classified

113

1.11

0.12

1.1

—

Disorders of gallbladder, biliary tract and pancreas

124

0.90

0.11

1.1

1.0

—

Gastrointestinal diseases

0.88

0.11

1.0

1.1

—

Gingivitis and periodontal diseases

119

0.91

0.11

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.12

0.10

1.0

—

Benign lipomatous neoplasm

1.09

0.09

1.0

—

Irritable bowel syndrome

1.09

0.09

1.0

—

Infections with a predominantly sexual mode of transmission

1.06

0.09

1.4

1.0

—

Other hearing loss

1.05

0.09

1.0

—

Impingement syndrome of shoulder

1.04

0.09

1.0

—

Injuries to the shoulder and upper arm

134

1.09

0.09

1.2

1.0

—

Oxicams

1.14

0.09

1.0

1.2

—

Uterine polyps

1.10

0.09

1.0

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

104

1.10

0.08

1.1

1.0

—

Spontaneous abortion

0.80

0.08

1.2

1.0

—

Bronchitis

136

0.93

0.08

1.1

1.0

—

Redundant prepuce, phimosis and paraphimosis

0.82

0.08

1.4

1.0

—

Retinal detachments and breaks

0.83

0.08

1.0

—

0.79

0.08

1.0

—

Diaphragmatic hernia

0.79

0.08

1.0

—

Insulin, fast-acting or short human

0.78

0.08

1.0

—

Acute bronchitis

1.09

0.08

1.1

1.0

—

Other/unspecified dorsalgia

1.08

0.08

1.1

1.0

—

Disorders of the thyroid gland

120

0.92

0.08

1.2

1.0

—

Cervical disc disorders

1.04

0.08

1.0

—

Other and unspecified tonsillitis

0.84

0.07

1.0

—

Glucosamine medication

0.83

0.07

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

102

0.89

0.07

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

123

1.08

0.07

1.0

1.1

—

Persons encountering health services in other circumstances, wide

125

1.07

0.07

1.1

1.0

—

Deviated nasal septum

0.86

0.07

1.0

—

Leiomyoma of uterus

1.07

0.07

1.0

1.1

—

Other anxiety disorders

0.83

0.07

1.0

—

Injuries to the thorax

0.84

0.07

1.0

—

Chronic sinusitis

0.84

0.07

1.1

1.0

—

Urinary track infection

0.85

0.07

1.0

—

Complications of labour and delivery

0.85

0.07

1.1

1.0

—

Transient ischemic attack

1.04

0.07

1.1

1.0

—

Acute tubulo-interstitial nephritis

103

0.90

0.07

1.0

—

Tonsillectomy and adenotomy

0.84

0.07

1.0

—

Disorders of vitreous body and globe

0.88

0.06

1.0

—

Low back pain

106

1.08

0.06

1.0

1.1

—

Varicose veins

0.86

0.06

1.0

—

Fracture of forearm

0.89

0.06

1.0

—

Dorsalgia

109

1.07

0.06

1.0

1.1

—

Hypothyroidism, strict autoimmune

100

0.92

0.06

1.1

1.0

—

Pneumonia, organism unspecified

128

1.07

0.06

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

116

1.07

0.06

1.2

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

118

0.93

0.05

1.1

1.0

—

Hypothyroidism, other/unspecified

113

0.93

0.05

1.3

1.0

—

Cholelithiasis

108

1.07

0.05

1.1

1.0

—

Implicit Sepsis

110

1.07

0.04

1.0

—

Injury, poisoning and certain other consequences of external causes

0.91

0.04

1.0

—

Lower back pain or/and sciatica

136

1.05

0.04

1.0

1.1

—

Zoster [herpes zoster], including avohilmo

1.10

0.04

1.0

—

Depression or dysthymia

1.06

0.03

1.2

1.1

—

Appendectomy

122

0.94

0.03

1.0

—

Any mental disorder

120

0.96

0.02

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

102

0.93

0.02

1.1

1.0

—

Anxiety disorders, excluding more controls

114

0.95

0.02

1.0

1.1

—

Anxiety disorders

129

0.96

0.02

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

116

0.94

0.02

1.1

—

Cholelithiasis, broad definition with cholecystitis

108

1.05

0.02

1.1

1.0

—

Chronic apical periodontitis

130

1.03

0.01

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

128

0.97

0.00

1.0

1.1

—

Pain in limb

111

1.03

0.00

1.1

—

Fall on same level

125

1.02

0.00

1.1

1.0

—

Exposure to unspecified factor

142

1.01

0.00

1.0

1.1

—

Psychiatric diseases

107

0.98

0.00

1.0

1.1

—

Injuries to the elbow and forearm

117

1.02

0.00

1.0

—

Bacterial Sepsis

1.05

0.00

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.03

0.00

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

105

0.95

0.00

1.1

1.0

—

Other diseases of urinary system

109

0.98

0.00

1.0

—

Lumbar disc prolapse

0.97

0.00

1.0

1.1

—

Cystitis

1.00

0.00

1.0

—

Infections of the skin and subcutaneous tissue

114

1.04

0.00

1.2

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

132

1.00

0.00

1.1

1.0

—

External causes of morbidity and mortality

0.99

0.00

1.0

—

Pure hypercholesterolaemia

100

1.02

0.00

1.0

—

Metabolic disorders

121

0.99

0.00

1.2

1.0

—

Erysipelas

1.00

0.00

1.0

—

Hypermobility syndrome

0.00

0.0

1.0

—

Other specified/unspecified bacterial intestinal infections

0.00

0.0

1.0

—

Convalescence

0.00

0.0

1.0

—

Collagenous colitis

0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.0

1.0

—

Other symptoms and signs involving the circulatory and respiratory systems

0.00

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

0.0

1.0

—

Crohn disease (strict definition, require KELA)

0.00

0.0

1.0

—

Deep bite

0.00

0.0

1.0

—

Mixed hyperlipidaemia

0.00

0.0

1.0

—

Vascular dementia

0.00

0.0

1.0

—

Enterocolitis due to Clostridium difficile

0.00

0.0

1.0

—

Polyarthritis, unspecified

0.00

0.0

1.0

—

Other necrotizing vasculopathies

0.00

0.0

1.0

—

Varicose veins of other sites

0.00

0.0

1.0

—

Other disorders of male genital organs

0.00

0.0

1.0

—

Diseases of peritoneum

0.00

0.0

1.0

—

Streptococcal septicaemia

0.00

0.0

1.0

—

Other orthopaedic follow-up care

0.00

0.0

1.0

—

Thyroiditis

0.00

0.0

1.0

—

0.00

0.0

1.0

—

Mandibular retrognathia

0.00

0.0

1.0

—

Infectious mononucleosis

0.00

0.0

1.0

—

Other enthesopathies

0.85

0.00

1.0

—

Demyelinating diseases of the central nervous system

0.00

0.0

1.0

—

Fibrosis and cirrhosis of liver

0.00

0.0

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.0

—

Other and unspecified injuries of lower leg

0.00

0.0

1.0

—

Other or ill-defined heart diseases

0.00

0.0

1.0

—

Hyperkalaemia

0.00

0.0

1.0

—

Infectious mononucleosis, including avohilmo

0.00

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.0

1.0

—

Injury of other and unspecified intrathoracic organs

0.00

0.0

1.0

—

Hordeolum and other deep inflammation of eyelid

0.00

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

-0.00

0.0

1.0

—

Other diseases of blood and blood-forming organs

0.00

-0.00

0.0

1.0

—

Otalgia

0.00

-0.00

0.0

1.0

—

Other infective otitis externa

0.00

-0.00

0.0

1.0

—

Postprocedural disorders of nervous system

0.00

-0.00

0.0

1.0

—

Lesion of plantar nerve

0.00

-0.00

0.0

1.0

—

Specific development disorders of scholastic skills

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to cannabinoids

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

1.0

—

Disorders of calcium metabolism

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

-0.00

0.0

1.0

—

Atypical facial pain

0.00

-0.00

0.0

1.0

—

Twin gestation

0.00

-0.00

0.0

1.0

—

Postmenopausal osteoporosis with pathological fracture

0.00

-0.00

0.0

1.0

—

Amputation of toe

0.00

-0.00

0.0

1.0

—

Abnormal findings on examination of blood, without diagnosis

0.95

-0.00

1.0

—

Tuberculosis, wide

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Adrenal gland

0.00

-0.00

0.0

1.0

—

Tuberculosis, wide, including avohilmo

0.00

-0.00

0.0

1.0

—

Crohn's disease NAS

0.00

-0.00

0.0

1.0

—

Haemangioma, any site

0.00

-0.00

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

1.0

—

Implicit fungal Sepsis, including avohilmo

0.00

-0.00

0.0

1.0

—

Use of galantamine

0.00

-0.00

0.0

1.0

—

Disorders of vitreous body

0.89

-0.00

1.0

—

Viral warts

0.00

-0.00

0.0

1.0

—

Rubella [German measles], including avohilmo

0.00

-0.00

0.0

1.0

—

Otosclerosis

0.00

-0.00

0.0

1.0

—

Rubella [German measles]

0.00

-0.00

0.0

1.0

—

Ménière disease

0.00

-0.00

0.0

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

0.97

-0.00

1.0

—

Sequelae of infectious and parasitic diseases

0.00

-0.00

0.0

1.0

—

Streptococcal septicaemia, including avohilmo

0.00

-0.00

0.0

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

0.92

-0.00

1.1

1.0

—

Other necrotizing vasculopathies (FG)

0.00

-0.00

0.0

1.0

—

Raynaud syndrome

0.00

-0.00

0.0

1.0

—

Recurrent dislocation of patella

0.00

-0.00

0.0

1.0

—

Left bundle-branch block

0.00

-0.00

0.0

1.0

—

Crossbite

0.00

-0.00

0.0

1.0

—

Fracture of shoulder and upper arm

0.92

-0.00

1.3

1.0

—

Fracture of neck

0.00

-0.00

0.0

1.0

—

Ulcerative proctitis

0.00

-0.00

0.0

1.0

—

Viral pneumonia (unknown virus, not influenza)

0.00

-0.00

0.0

1.0

—

Polyp of the female genital tract

1.03

-0.00

1.0

1.1

—

Cerebral aneurysm, nonruptured

0.00

-0.00

0.0

1.0

—

Persistent delusional disorders

0.00

-0.00

0.0

1.0

—

Scleritis and episcleritis

0.00

-0.00

0.0

1.0

—

Unspecified dementia

0.00

-0.00

0.0

1.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

-0.00

0.0

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

1.0

—

Obsessive-compulsive disorder

0.00

-0.00

0.0

1.0

—

Non-allergic asthma

0.00

-0.00

0.0

1.0

—

Asthma mixed form (mode)

0.00

-0.00

0.0

1.0

—

Care involving dialysis

0.00

-0.00

0.0

1.0

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

0.94

-0.00

1.0

—

Eating disorders

0.00

-0.00

0.0

1.0

—

Schizoaffective disorder

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.0

—

Episcleritis

0.00

-0.00

0.0

1.0

—

Osteonecrosis

0.00

-0.00

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

-0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Astigmatism

0.00

-0.00

0.0

1.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

-0.00

0.0

1.0

—

Other ulcerative colitis

0.00

-0.00

0.0

1.0

—

Cholangitis (primary sclerosing, PSC)

0.00

-0.00

0.0

1.0

—

Unspecified fall

1.00

-0.00

1.0

—

Foreign body in respiratory tract

0.00

-0.00

0.0

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

-0.00

0.0

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

0.94

-0.00

1.0

—

Persons encountering health services in other circumstances

0.95

-0.00

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS